title: Th17 cells, pathogenic or not? TGF-β3 imposes the embargo.
authors: Unité 872, Institut National de la Santé et de la Recherche Médicale, Paris, France.
authors: Meenu
authors: M
authors: Sharma
authors: Srini V
authors: SV
authors: Kaveri
authors: Jagadeesh
authors: J
authors: Bayry
mesh_terms: D000818:Animals; D001327:Autoimmune Diseases / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D002454:Cell Differentiation / Q000276:immunology; D006801:Humans; D007249:Inflammation / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D053759:Interleukin-23 / Q000096:biosynthesis; D051379:Mice; D058504:Th17 Cells / Q000166:cytology / Q000276:immunology* / Q000473:pathology*; D053782:Transforming Growth Factor beta3 / Q000502:physiology*
chemical_list: D053759:Interleukin-23; D053782:Transforming Growth Factor beta3
references: J Exp Med. 2009 Jul 6;206(7):1549-64
references: 19546248
references: Am J Pathol. 2012 Jul;181(1):8-18
references: 22640807
references: J Allergy Clin Immunol. 2010 Jan;125(1):222-30.e1-4
references: 20109749
references: Nat Immunol. 2012 Oct;13(10):991-9
references: 22961052
references: Nature. 2006 May 11;441(7090):235-8
references: 16648838
references: Nature. 2011 Jul 17;475(7357):514-8
references: 21765430
references: Cell Mol Immunol. 2012 Jul;9(4):287-95
references: 22504954